Asthma Management A Stepwise Approach. Objectives. Prevalence of Asthma. Increasing Globally. Costs. Disclosure - None 9/23/2013
|
|
- Cecilia Stokes
- 6 years ago
- Views:
Transcription
1 Asthma Management A Stepwise Approach Disclosure - None Jane Cooper, RN, FNP- BC, CORLN University of Missouri Health Care Depart. of Otolaryngology Head and Neck Surgery Columbia, Missouri Objectives Review definition and diagnosis of asthma Discuss the 4 components of asthma management Regular monitoring airflow measurements Control of environmental triggers and comorbid conditions Medication Take correctly Patient education partnership Examine the 2007 NAEEP Guidelines for Stepwise Approach Review asthma medications Discuss asthma management in the ENT patient. Prevalence of Asthma According to CDC and Prevention, an estimated 7.1 million children ( 9.5%)have asthma, making it the most common pediatric chronic illness in America. 1. Leading cause of school absenteeism. Average 30 kids in classroom, 3 will have asthma. Number of adults in the U.S. with asthma is 18.9 million or 8.2%. 2. WHO estimates 235 million people worldwide suffer from asthma. 1. CDC and Prevention. Healthy Youth: Asthma. Accessed July 29, Accessed July 29, Increasing Globally Sharp increase in the global prevalence, morbidity, mortality, and economic burden associated with asthma over the last 50 years, mostly in children, as the most common chronic disease. The increase parallels the increase of atopic diseases worldwide. Probably due to urbanization of communities. Braman,SS. Asthma Guidelines in Day-To-day Practice. Pulmao RJ 2012;21(2): Costs Treating asthma patients under the age of 18 costs an estimated 3.2 billion per year. Asthma causes 12.8 million lost school days in kids yearly. Children from low income families have a higher prevalence of asthma and are 3 times more likely to have acute exacerbations leading to ED visits. Adults lose 14.5 million work days yearly due to asthma. Centers of Disease Control and Prevention. FastStats: Asthma. Accessed August 10,
2 Asthma Guidelines The asthma guidelines were first published in 1991 by the National Heart, Lung, and Blood Institute (NHLBI) and National Asthma Education and Prevention Program (NAEPP). Updated in 1997, 2002 and The Guidelines provide medically evidenced best practice methodology for treating asthma. Despite guidelines, asthma has continued to be challenging to manage. There are discrepancies between what providers prescribe and teach and the care patients receive. Asthma is often under diagnosed and inappropriately treated. Rance,KarenUnderstanding and Implementing the New NHLBI Asthma Guidelines. J for Nurse Practitioners. 2008; April Guideline Changes New Emphasis On Monitoring asthma control as goal for therapy. Distinguish between asthma Severity and monitoring asthma Control. Provider should gauge impairment and risk as two components in determining the Level of Asthma Control. Multifaceted approaches to Pt education and to control environmental factors and co-morbid conditions that affect asthma. (allergy, reflux etc) Changes in managing asthma long term. (Step up and down) Step down medications after 3 months of stability Changes to treatment for managing asthma exacerbations. Rance, Karen GINA Global Initiative for Asthma Global strategy to provide a roadmap for improved allergy care. 1. Use objective measures, such as spirometry to diagnose and monitor response to treatment. 2. Provide advice for effective environmental control. 3.Use the step-up approach for pharmacological therapy. 4.Develop a partnership of care with patient or caregiver. Global Strategy for asthma management and prevention. (GINA) Updated Asthma is Chronic inflammatory disorder of the airways Episodic and reversible airflow obstruction Airway Hyper -Responsiveness Subsequent narrowing of small airways Common Symptoms Wheezing, Cough, Shortness of breath and chest discomfort htm&docid=heerkcqyomsomm&imgurl= &ved=1t:429,r:52,s:0,i:249&tx=133&ty=49 2
3 Etiology of Asthma is not clear. Complex disease with many immunological variables. Many different cell types ( dendritic, T cells, TH1 and TH2) and cytokines ( IL-4, IL-13 and IL-5) that play critical roles in asthma pathogenesis. Asthma Pathways Diagnosis Clinical Evaluation Detailed history Allergy exposure: Home, school, work environment Smoke and chemical exposure Smoking ( active and passive) Viral infections Diagnosis Asthma Triggers Clinical picture - cough, SOB, wheezing etc.. Spirometrywith flow volume loops or PFTs give information on breathing patterns. Evidence of obstructive breathing, improved with use of bronchodilator. + Bronchodilator response: FEV1 increased by 200 ml + 12% OR FVC increased by both 200 ml + 12%. Exhaled nitric oxide (if high can indicate inflammation) Allergy Evaluation- Skin prick test or lab Chest X-ray Lab CBC with diff (Eosinophils), IgE, sweat chloride/genetic tests for CF, Vitamin D 3
4 Food Allergy Asthma Triggers Milk Egg Peanut Tree Nuts Wheat Soy Shellfish Fish Most Allergic Foods Asthma Management asthmainstitute.pitt.edu The University of Pittsburgh AsthmaInstitute - Tobacco smoke Smoke from wood stoves and fireplaces Perfume Cleaning Products Air pollution Nail and hair products Regular monitoring of symptoms and lung function Control of the environmental triggers and comorbid conditions that contribute to asthma severity Pharmacologic Therapy Patient Education - Partnership Asthma Control TestR 5 questions designed to help a patient describe their symptoms and how they are feeling. 1. In the past 4 weeks, how much of the time did your asthma keep you from getting as much done at home? All of the time Most of the time Some of the time A little of the time None of the time During the past 4 weeks, how often have you had shortness of breath? All of the time Most of the time Some of the time A little of the time None of the time Kosinsski, M, Bayliss, MS, Turner-Bowker, DM, Fortin,EW. Asthma Quality Control Test: A Users Guide, Lincoln (RI): QualityMetric, Incorporated, QualityMetric. Asthma Control Test 3. In the past 4 weeks, how often did your asthma symptoms (wheezing, cough, SOB, chest tightness or pain) wake you up at night or earlier than usual in the morning? 4 or more 2-3 nights a week once a week Once or twice Not at all nights a week In the past 4 weeks, how often have you used your rescue inhaler or nebulizer medication (Albuterol, Maxair or Primatene Mist)? 3 or more 1-2 times/day 2-3 times/week 1 time week Not at all How would you rate your asthma control during the past 4 weeks? Not Poorly Somewhat Well Completely controlled controlled controlled controlled controlled
5 Asthma Control Test Results: 5 to 15 Poorly Controlled 15 to 20 Somewhat Controlled 20 to 25 Controlled A tool to help educate patients and parents. Help raise awareness of how they are doing. Not a diagnostic tool. Ages 12 to adult. Monitoring Asthma Spirometry Measures forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) Reduced Ratios of (FEV1/FVC ) can help determine restriction or obstruction. The 2007 NAEPP (National Asthma Education and Prevention Program) guidelines recommend using spirometryin practices that routinely care for asthma patients. Monitoring Asthma Peak expiratory flow rate (PEFR) Ages 5 to adult Benefits:Inexpensive ($20), convenient can be done at home, useful for detecting changes in asthma control Limitations: Measurements are dependent on the patient s technique. A reduced peak flow reading does not always indicate airway obstruction. The patient establishes a baseline measurement when feeling well personal best. Readings below the range may indicate narrowing of the airway and prompt implementing the Asthma Action Plan Reduce Impairment Freedom from symptoms Minimal need (< 2x per week) of short acting beta agonists (SABAs ) to relieve symptoms. Optimal lung function Maintaining normal ADL. School, work, athletics and exercise Patients and families are satisfied with asthma care UptoDate An Overview of Asthma Management, Author Fanta, Christopher MD Accessed 12/31/12 Asthma Severity First step is to classify severity of the asthma How is asthma classified? Look at 3 factors Reported symptoms over the previous 2-4 weeks Current level of lung function Number of exacerbations requiring the use of oral steroids per year. Four Categories of Asthma Severity Intermittent Mild Persistent Moderate Persistent Severe Persistent NAEPP: Expert Panel Report III: Guidelines for the diagnosis and management of asthma. (NIH publication no ). Bethesda, MD: National Heart, Lung, and Blood Institute, (Accessed on July 29, 2013). 5
6 Intermittent Asthma Daytime asthma sxsoccur 2 or less days per week 2 or less night time awakenings per month Use of short-acting beta agonists (SABA) < 2x per week Normal activity between exacerbations FEV1 readings are normal (80% or higher of predicted nomal) between exacerbations. Rx - SABA Step 1 for starting treatment Mild Persistent Sxs> 2x per week, but less than daily Use of SABA > 2x week, but not daily Nocturnal awakenings 3-4 x per month Mild interference with activities Spirometry within normal range Use of oral steroids 2 or more times a year Rx Low dose ICS or montelukast(singulair), Cromolyn Step 2 for starting treatment Moderate Persistent Daily asthma sxs Nocturnal awakenings > once a week Daily need of SABA Decrease in normal activity FEV1 -between 60-80% of predicted FEV1/FVC below normal Use of oral steroids > 2x year Step 3 for starting treatment Severe Persistent Have one or more Asthma sxs throughout the day Nightly awakenings Need for SABA several times daily Normal activity is extremely limited FEV1 < 60% of predicted Step 3 (age 0-4) Step 3 or 4 (5-11) Step 4 or 5 (> 12) Assessing Control Classifying Asthma Severity Ages 12 - Adult Well Controlled Not Well Controlled Very Poorly Controlled Maintain current step Consider step down if well controlled for at least 3 months Step up 1 step and reevaluate in 2-6 weeks For side effects, consider alternative treatment Consider short course of oral corticosteroids Step up 1-2 steps and reevaluate in 2 weeks For side effects consider alternative treatment options 6
7 Assessing Asthma Control - Ages 12 - Adult Managing Asthma ages 12 to Adult Managing asthma ages 12 to adult Short Acting Beta-2 Agonists -SABA Potent bronchodilator Dilates the bronchial smooth muscle. Medication of choice for intermittent asthma, exercise induced bronchoconstriction and a rescue medication. Dose: Prevention and treatment: 2 inhevery 4-6 hrs, can decrease to 1 inh. Prevention of EIB: > 4 yr Give 2 inh15 minutes before exercise. Quick relief of symptoms Onset min Adverse Reactions: Nervousness, tremor, HA, cough, tachycardia, GI upset, dizziness, hyperactivity, throat irritation, insomnia. Albuterol ProAir HFA Proventil HFA, Ventolin HFA MDI are 90 mcg. Solution for inh0.5% 0.083% VoSpire ER (tablets) 4 mg 8 mg tabs Dose: Adults: 4 8 mg every 12 hours. Max. 32 mg/day Child: age 6 on up. 4mg every 12 hours, max 24 mg/day Asthma Exacerbation For asthma exacerbations requiring an ER visit albuterol remains the drug of choice If the person has good technique of the MDI, 2 6 puffs using a spacer or Aerochambermask. Repeat after 20 minutes up to 3 doses then every one to four hours as needed. 7
8 SABA continued Levalbuterol Xopenex Solution (nebulizer) Ages 6-11 yrs. 0.31mg by neb Tid > 12 yrs. 0.63mg Tidcan increase to 1.25 mg Levalbuterol- Xopenex HFA 45 mcg MDI Not recommended for children < 4 yrs. > 4 yrs 2 inhevery 4-6 hrs, or 1 inhevery 4 hrs allergyasthmatech.com Facts About AsthmaPrevention - Allergy AsthmaTech Adverse reactions: Single -isomer of albuterol, similar side effects. Giving Asthma Medicationsto a Child: Some Great Videos Craig... drcraigcanapari.com There is no significant difference between albuterol or levalbuterol in efficacy, safety or prevalence of adverse side effects. Use should be reserved for those with known adverse effects from albuterol. Uptodate.com/content/beta-agonists-in asthma-acute administration and prophylactic use. Accessed 7/18/13 SABA continued Pirbuterol- Maxair Autohaler 200mcg per inhalation breath actuated MDI Age 12 to Adult Dose is 1-2 inhevery 4-6 hours Max of 12 inhper day Not studied for use in severe asthma exacerbation LABA Long-acting beta agonists have a long lipophilic side chain that increases the duration of binding the drugs to the adrenergic receptor. Causes a longer duration of action Salmeterol and formoterol Used with ICS for those with moderate or severe asthma not controlled with ICS alone. Have an additive effect with ICS when combined Not used in monotherapy. Leukotriene Receptor Antagonist LTRA Leukotrienes(LTC4, LTD4 and LTRA) are strong bronchoconstrictors and pro-inflammatory agents. Found in nasal secretions, sputum and bronchoalveolarlavage fluid in asthma patients Can be used in addition to ICS for daily treatment of persistent asthma in kids > 1 yr. Orin mild persistent asthma as step down therapy from ICS. Montelukast- Singulair Approved for ages > 1 yrfor asthma and 6 months or greater for rhinitis. Dosages: 4 mg granules or chewable tab ages mg chewable tab ages mg 15 and older Adverse Effects: URI, fever, cough, headache, pharyngitis, abdominal pain, diarrhea 8
9 What does the evidence show? Compared to placebo: A randomized DB study for children ages 2-5 years with intermittent asthma triggered by viral infections. 270 children in each group and given placebo or montelukast for one year. Results: Those on montelukast had 32% less asthma exacerbations (from 2.3 to1.6) and decreased used of ICS. Compared to ICS: Many studies for adults and children have shown ICS to be more effective than LTRAs in treating asthma for most patients. Two comparison studies of fluticasone and montelukast in children aged 6-14, reported fewer asthma attacks, increased pulmonary measures, and less nighttime symptoms with those using fluticasone only. Intermittent Use LTRA More information needed to confirm if taking montelukast at the onset of increased asthma or URI symptoms can be encouraged for children with intermittent asthma. Summary: Consider using montelukast in addition to a ICS for persistent asthma. Or when stepping down from ICS in mild persistent asthma. children - accessed July, Inhaled Corticosteroids - ICS For long term asthma control If night awakenings are > 1x week Use of oral steroids > 2x a year Limitations of normal activity Addition of ICS prevents loss of lung function Increase quality of life Decreases risk of severe exacerbations ICS Adverse Reactions- Most Common Headache Rhinitis URI Pharyngitis Oral symptoms with MDI Increased asthma symptoms In young children average 1.1cm reduction in rate of growth in first year of Rx. A temporary, not a progressive slowing. PEAK STUDY (Prevention of Early Asthma in Kids) monitored 285 kids over 2-3 years. ICS Pulmicort budesonide Flexhaler (dry pwd) inhaler Respules ( susp) QVAR beclomethasone MDI ICS Alvesco ciclesonide (MDA) age 12 > Asmanex mometasone (dry pwd) age 4 > Flovent fluticasone ( MDI, dry pwddiskus) age 4> 9
10 Combined ICS + LABA Fluticasone/salmeterol Advair age 4 > DPI 100 mcg/ 50 mcg 250 mcg/ 50 mcg 500 mcg/ 50 mcg 45 mcg-21mcg MDI 115 mcg-21mcg 230 mcg-21mcg Mometasone/formoterol Dulera Adults MDI 100 mcg/5 mcg 200 mcg/5mcg Budesonide/formoterol Symbicort Adults MDI 80 mcg/4.5 mcg 160 mcg/4.5 mcg ICS + LABA Use when asthma symptoms not adequately controlled on a medium or higher dose of asthma-controller medications. Likely Moderate persistent asthma Step 3 on the Asthma Rx Guidelines Anti-IgE Therapy Omalizumab Xolair Approved for ages 12 and up in the U.S. In other countries used down to age of 6. Used to treat moderate to severe asthma that is not well controlled with standard medications. IgElevel of 30 to 700 IU/ml, + allergen skin test or IgEto a perennial allergen. Dose is given SQ every 2-4 weeks. Response rate is 30 50% Minimum of a 12 week Rx is needed to reach efficacy. Before Adding More Meds: ICE Inhaler technique Check patient's technique. Compliance Ask when and how much medication the patient is taking. Environment Ask patient if something in his or her environment has changed. Is there environmental tobacco smoke in the home? Find out about cotinine levels, which can help track exposure to tobacco smoke and its toxic constituents using a saliva, blood or urine test. You may also want to consider an alternative diagnosis. Assess patient for presence of other upper respiratory disease. Adapted from the Practical Guide for the Diagnosis and Management of Asthma, NIH Publication, August 2007, National Institutes of Health, National Heart, Lung and Blood Institute Cost Comparison of Asthma Medications Article: Cost Effective Asthma Treatments for Uninsured or Underinsured Pediatric Patients by KarlenE. Luthy, DNP, FNP, EmilianneDougall, MS, FNP and Renea L Beckstrand, PhD, CCRN Journal of Nurse Practitioners, Vol 8, Issue 8, Sept Identified studies related to the treatment of pediatric patients with asthma. Used an online pharmacy, drugstore.com to collect cost-related information. Step 1 Recommendation: Albuterol most cost effective for HFA and soln Step 2 Recommendation: Low dose beclomethasone (Qvar) Step 3 Recommendation: Medium-dose beclomethasone + SABA Patient Education Foster a partnership with patient and family. Discuss goals of asthma care Self management education Review actions of medications and potential side effects Written Asthma action plan for daily use and for exacerbation. Know when to use oral steroids, when to call Provider and when to seek emergency care. 10
11 Asthma ReadyTM Communities Asthma Patient Case Study A Missouri program developed by Ben Francisco, PhD, PNP, AC-E aimed at improving asthma care by educating teachers, school nurses and other pediatric health care professionals. He s spent over 14 years of studying and proving the effectiveness of different types of education on the treatment of kids with asthma. Uses live instruction and web-based lessons to train Missouri s professionals. So far, over 900 persons have been educated. His Four main messages about Asthma Education Daily medication can stop asthma. They work only if taken correctly. Airflow measures are critical to know if a child s asthma is under control Environmental factors, such as high allergen areas, are a critical factor that will influence how well a child s asthma is controlled. ENT Considerations Ask about asthma symptoms and level of control Ask about triggers and exposure at home, work and school Test and treat for allergies. Consider reflux Do Spirometry if you treat for allergy. Print out the Asthma guidelines keep handy Know when to refer to Pulmonary or asthma specialist References Center of Disease Control and Prevention. FastStats: Asthma. Accessed 7/28/13 CDC and Prevention, Healthy Youth: Asthma. youth/asthma. Accessed July 29, American Academy of Allergy, Asthma and Immunology. Asthma accessed July 29, National Heart, Lung and Blood Institute. Expert Panel report (EBR3) Guidelines for the diagnosis and management of asthma:section4, managing asthma longtermin children 0-4 yrs of age and age /18/2013. National Heart,Lungand Blood Institute. Expert panel report (EPR3): Guidelines for the diagnosis and management of ashtma:sec.3, component 4:medications. http//www. Nhlbi.nih.gov/guidelines/asthma/07_sec3_comp4.pdf. Accessed 7/18/2013. Global Strategy for asthma management and prevention (GINA) updated files. 7/18/2013. BramanSSAsthma Guidelines in Day-to-day Practice Pulmao RJ 2012;21(2): References RanceK. Understanding and Implementing the New NHLBI Asthma Guidelines. J Nurs Pract : Apr LuthyKE, Dougall, E, Beckstrand,R. Cost Effective Asthma Treatments for Uninsured or Underinsured Pediatric Patients. J Nurse Prac 2012:8( Up to Date -asthma-in-children-youngerthan 12 years and An overview of asthma management.accessed 12/31/12. Up to Date administration and prophylactic use. Accessed 7/18/13 Up to Date of moderate persistent asthma in adolescents and adults and treatment of severe asthma in adolescents and adults. Accessed 8/29/13. Asthma Education for missouri. Accessed 2/14/13. Rank,Met al. Factors associated with decisions to step down asthma medications. J of Allergy and Clinical Immunology. May 2013 Vol.1, Issue 3 pages /2011/07/22/school-choice-hospitalanalogy/&docid=HF1BVpxYUhGSQM&imgurl= announc.jpeg%253fw%253d506%2526h%253d412&w=506&h=412&ei=fjxxudhafzcjqqgiodwcg&zoom=1&iact=rc&page=2&tbnh=145&tbnw=174&start=38&ndsp=51&ved=1t:429,r:42,s:0,i:212& tx=84&ty=82 11
12 12
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More information12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationASTHMA IN THE PEDIATRIC POPULATION
ASTHMA IN THE PEDIATRIC POPULATION SEARCH Rotation 2 August 23, 2010 Objectives Define asthma as a chronic disease Discuss the morbidity of asthma in pediatrics Discuss a few things that a health center
More informationAsthma 2015: Establishing and Maintaining Control
Asthma 2015: Establishing and Maintaining Control Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C June 16, 2015 Asthma Prevalence Approx. 26
More informationFoundations of Pharmacology
Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids
More informationGINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017
GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and
More informationII: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical
Table 3.1. Classification of COPD Severity Stage Pulmonary Function Test Findings Symptoms I: Mild Mild airflow limitations +/ Chronic cough and sputum production; patient unaware of abnormal FEV 1 80%
More informationAsthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationKey features and changes to these four components of asthma care include:
Guidelines for the Diagnosis and Management of Asthma in Adults Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions regarding
More informationEffective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017
Protocol Title: Adult Asthma Protocol Effective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017 1 Purpose & Objective This protocol provides evidence-based
More informationAsthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationAllergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma
Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going
More informationImproving the Management of Asthma to Improve Patient Adherence and Outcomes
Improving the Management of Asthma to Improve Patient Adherence and Outcomes Robert Sussman, MD Atlantic Health System Overlook Medical Center Asthma Remains a Serious Health Risk in the US Every day in
More informationASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015
ASTHMA BEST PRACTICES FOR SCHOOL NURSES School Nurses November 2015 1 BACKGROUND AND CURRENT STATS General definitions and explanations 2 Incidence of Asthma Centers for Disease Control (CDC) - 1 in 12
More informationAsthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION
Asthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION Asthma Management in Pregnancy Effects of asthma on pregnancy outcomes Effects of pregnancy on asthma control Management
More informationAlberta Childhood Asthma Pathway for Primary Care
Asthma Diagnosis Box 1 Diagnosis: Based on symptom pattern, careful and thorough history of symptoms (wheeze, cough, night waking and activity limitations), and assessment of family history of asthma and
More informationGlobal Initiative for Asthma (GINA) What s new in GINA 2016?
Global Initiative for Asthma (GINA) What s new in GINA 2016? GINA Global Strategy for Asthma Management and Prevention GINA: A Brief History Established in 1993 Collaboration between NHLBI and WHO Multiple
More informationMANAGING ASTHMA. Nancy Davis, RRT, AE-C
MANAGING ASTHMA Nancy Davis, RRT, AE-C What is asthma? Asthma is a chronic respiratory disease characterized by episodes or attacks of inflammation and narrowing of small airways in response to asthma
More informationIn 2002, it was reported that 72 of 1000
REPORTS Aligning Patient Care and Asthma Treatment Guidelines Eric Cannon, PharmD Abstract This article describes how the National Asthma Education and Prevention Program Guidelines for the Diagnosis and
More informationAsthma in Pediatric Patients. DanThuy Dao, D.O., FAAP. Disclosures. None
Asthma in Pediatric Patients DanThuy Dao, D.O., FAAP Disclosures None Objectives 1. Discuss the evaluation and management of asthma in a pediatric patient 2. Accurately assess asthma severity and level
More informationAmanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ
Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ Financial Disclosures Advanced Practiced Advisory Board for Circassia Learning Objectives 1. Briefly
More informationNancy Davis, RRT, AE-C
Nancy Davis, RRT, AE-C Asthma Statistics 25.6 million Americans diagnosed with asthma 6.8 million are children 10.5 million missed school days per year 14.2 lost work days for adults Approximately 10%
More informationThe Asthma Guidelines: Diagnosis and Assessment of Asthma
The Asthma Guidelines: Diagnosis and Assessment of Asthma Christopher H. Fanta, M.D. Partners Asthma Center Brigham and Women s Hospital Harvard Medical School Objectives Know how the diagnosis of asthma
More informationAsthma By Mayo Clinic staff
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationControversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies
Controversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies Stanley J. Szefler, MD Helen Wohlberg and Herman Lambert Chair in Pharmacokinetics, Head, Pediatric
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationPediatric Asthma Management
Pediatric Asthma Management APRN Conference February 2016 Cheryl Kerrigan, MSN, CPNP Aimee Tiller RN, AE-C The Plan Definition Pathophysiology review Triggers & Risk Factors Incidence and Prevalence Making
More informationAsthma. Definition. Symptoms
Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP 3 Main Categories Inhaled Respiratory Drugs Binds to beta-2 receptors Relaxation of smooth muscles in the lung
More informationDrug Class Monograph
Drug Class Monograph Class: Inhaled Corticosteroids Drugs: Aerospan (flunisolide), Advair Diskus, Advair HFA (fluticasone/salmeterol), Alvesco (ciclesonide), Arnuity Ellipta (fluticasone furoate), Asmanex
More informationRobert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network
Robert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network Robert.kruklitis@lvh.com Correlation of a Asthma pathophyisology with basic science Asthma (Physiology) Bronchodilators
More informationDiagnosis, Treatment and Management of Asthma
Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
More informationPresented by the California Academy of Family Physicians 2013/California Academy of Family Physicians
Family Medicine and Patient-Centered Asthma Care Presented by the California Academy of Family Physicians Faculty: Hobart Lee, MD Disclosures: Jeffrey Luther, MD, Program Director, Memorial Family Medicine
More informationAir Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.
Asthma Air Flow Limitation In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation. True whether reversible, asthma and exercise-induced bronchospasm,
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP October 23, 2017 Learning Objectives Be able to list at least 3 major adverse effects of inhaled medications
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
Adverse Effects of Inhaled Medications A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP June 28, 2017 Drug Category Beta 2 agonists antagonists Adverse Effects
More informationLearning the Asthma Guidelines by Case Studies
Learning the Asthma Guidelines by Case Studies Timothy Craig, DO Professor of Medicine and Pediatrics Distinguished Educator Penn State University Hershey Medical Center Objectives 1. Learn the Asthma
More informationAdult Asthma Clinical Practice Guideline Summary
Adult Asthma Clinical Practice Guideline Summary The following evidence-based guideline was developed to assist Primary Care physicians and other clinicians in the management of asthma in adults. It was
More informationTaking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP
Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP Associate Dean for Clinical Education and External Affiliations & Professor
More informationAsthma: Chronic Management. Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015
Asthma: Chronic Management Yung-Yang Liu, MD Attending physician, Chest Department Taipei Veterans General Hospital April 26, 2015 Global Strategy for Asthma Management and Prevention Evidence-based Implementation
More informationInhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution
More informationPediatric and Adult. Disclosure. Asthma. Learning Objectives. EPR-3: What s Changed? Asthma: Pediatric and Adult
Asthma: Pediatric and Adult Americo D. Fraboni, MD, FAAFP Assistant Clinical Professor Department of Family Practice & Community Health University of Minnesota Medical School Minneapolis, Minnesota Disclosure
More informationAsthma in the Athlete
Asthma in the Athlete Jorge E. Gomez, MD Associate Professor Texas Children s Hospital Baylor College of Medicine Assist Team Physician UH Understand how we diagnose asthma Objectives Be familiar with
More informationAsthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital
Asthma Update - 2013 A/Prof. John Abisheganaden Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital Asthma A complex syndrome Multifaceted disease Heterogeneous Genetic and
More informationPredicting, Preventing and Managing Asthma Exacerbations. Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa
Predicting, Preventing and Managing Asthma Exacerbations Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa Asthma exacerbations Predicting exacerbation recognising
More informationUsing Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?
Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Lindsay Thomas, Pharm.D. PGY2 Ambulatory Care Resident Department of Pharmacotherapy and Pharmacy
More informationMedications Affecting The Respiratory System
Medications Affecting The Respiratory System Overview Asthma is a chronic inflammatory disorder of the airways. It is an intermittent and reversible airflow obstruction that affects the bronchioles. The
More informationClinical Policy: Omalizumab (Xolair) Reference Number: ERX.SPA.141 Effective Date: Last Review Date: 08.17
Clinical Policy: (Xolair) Reference Number: ERX.SPA.141 Effective Date: 03.01.14 Last Review Date: 08.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationPrimary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD
Primary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor
More informationLearning Objective. Asthma. Discuss the pathophysiology, clinical presentation, diagnosis, and treatment of Asthma 2/22/2017
Marianne Curran, PA C 3/1/17 Learning Objective Discuss the pathophysiology, clinical presentation, diagnosis, and treatment of Definition many variations Chronic Disorder with Reversible (Intermittent
More informationAdult asthma management: focus on control
Adult asthma management: focus on control Jennifer W. McCallister, MD Associate Professor Pulmonary, Allergy, Critical Care & Sleep Medicine The Ohio State University Wexner Medical Center Objectives Apply
More informationRespiratory Health. Asthma and COPD
Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory
More informationDR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL
DR REBECCA THOMAS CONSULTANT RESPIRATORY PHYSICIAN YORK DISTRICT HOSPITAL Definition Guidelines contact complicated definitions Central to this is Presence of symptoms Variable airflow obstruction Diagnosis
More informationHealthPartners Care Coordination Clinical Care Planning and Resource Guide ASTHMA
The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH National Heart, Lung, and Blood Institute (NHLBI) and American Academy of Allergy,
More informationReference Guide for Caring for Pediatric Patients with Asthma
Reference Guide for Caring for Pediatric Patients with Asthma Co-Chair: Nancy Cantey Banasiak, DNP, PPCNP-BC, APRN Co-Chair: Deborah Hickman, DNP, APRN-CNP, CPNP-PC, NNP-BC Asthma and Allergy SIG Members
More informationImproving Outcomes in the Management & Treatment of Asthma. April 21, Spring Managed Care Forum
Improving Outcomes in the Management & Treatment of Asthma April 21, 2016 2016 Spring Managed Care Forum David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health University
More informationMeeting the Challenges of Asthma
Presenter Disclosure Information 11:05 11:45am Meeting the Challenge of Asthma SPEAKER Christopher Fanta, MD The following relationships exist related to this presentation: Christopher Fanta, MD: No financial
More informationInhaler Confusion. Today s Speaker Dr. Randall Brown. Director of Asthma Programs 6/7/2016. Dr. Randall Brown March 31, 2016
+ Inhaler Confusion Dr. Randall Brown March 31, 2016 + Today s Speaker Dr. Randall Brown Director of Asthma Programs Center for Managing Chronic Disease University of Michigan 1 ASTHMA ESSENTIALS IN PRIMARY
More informationBUDESONIDE AND FORMOTEROL (SYMBICORT ): Α A REVIEW
Volume 23, Issue 3 December 2007 BUDESONIDE AND FORMOTEROL (SYMBICORT ): A REVIEW Donna L. Smith, Pharm. D. Candidate More than 22 million people in the United States have asthma according to the Centers
More informationAsthma Essentials: Keys to Best Practice in Asthma Care
39 th National Conference on Pediatric Health Care March 19-22, 2018 CHICAGO Disclosures Asthma Essentials: Keys to Best Practice in Asthma Care Tammy Rood has no relationship with any commercial firm
More informationTips on managing asthma in children
Tips on managing asthma in children Dr Ranjan Suri Consultant in Respiratory Paediatrics Bupa Cromwell Hospital Clinics: Friday (pm) Asthma in Children Making the diagnosis Patterns of childhood asthma
More informationDisclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015
Disclosure Asthma: A GINA Update to the NAEPP 2007 Guidelines Robert (RC) Hellinga, Pharm.D. PGY 1 Pharmacy Resident Wolfson Children s Hospital/Baptist Health I do not have a vested interest in or affiliation
More informationAsthma ASTHMA. Current Strategies for Asthma and COPD
Current Strategies for Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor of Medicine Chair, Department of Medicine University of California San Francisco (UCSF) San Francisco,
More informationDrug Prior Authorization Guideline NUCALA (mepolizumab)
Drug Prior Authorization Guideline MB9914 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Restricted to Pulmonology, Allergy, and
More informationAerospan (flunisolide)
STRENGTH DOSAGE FORM ROUTE GPID 80mcg/actuation HFA aerosol inhaler w/ Inhaled 35718 8.9 g/canister adapter MANUFACTURER Meda Pharmaceuticals INDICATION Aerospan Inhalation Aerosol is indicated for the
More informationFASENRA (benralizumab)
FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationDifficult Asthma Assessment: A systematic approach
Difficult Asthma Assessment: A systematic approach Dr Naghmeh Radhakrishna Respiratory, Sleep & Allergy Physician Allergy, Asthma & Clinical Immunology Service The Alfred Hospital Melbourne, Australia
More informationGetting Asthma treatment right. Dr David Cremonesini Specialist Pediatrician American Hospital
Getting Asthma treatment right Dr David Cremonesini Specialist Pediatrician American Hospital cdavid@ahdubai.com } Consultant Paediatrician from UK of 5.5 years } Speciality in Allergy / Asthma (PG Certificate)
More information10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C
Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines
More informationAsthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.
Asthma Asthma Description Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Symptoms of asthma In susceptible individuals, this inflammation causes recurrent
More informationAsthma and Vocal Cord Dysfunction
Asthma and Vocal Cord Dysfunction Amy L. Marks DO, FACOP Pediatric Allergy and Immunology Assistant Professor of Pediatrics Oakland University William Beaumont School of Medicine Objectives: Understanding
More informationDual-Controller Asthma Therapy: Rationale and Clinical Benefits
B/1 Dual-Controller Asthma Therapy: Rationale and Clinical Benefits MODULE B The 1997 National Heart, Lung, and Blood Institute (NHLBI) Expert Panel guidelines on asthma management recommend a 4-step approach
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationClinical Guideline for the Diagnosis, Evaluation, and Management of Adults and Children with Asthma
Clinical Guideline for the Diagnosis, Evaluation, and Management of Adults and Children with Asthma - 2005 Criteria that suggest the diagnosis of Asthma: The symptoms of dyspnea, cough and/or wheezing,
More informationAsthma. Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital. Figure 1 Asthma Prevalence,
Asthma Rachel Miller, MD, FAAAAI Director Allergy and Immunology New York Presbyterian Hospital Figure 1 Asthma Prevalence, 1980-2000 * Gap between 1995-1996 and 1997 indicates a break in trend due to
More informationWorking Together to Better Manage Childhood Asthma
Working Together to Better Manage Childhood Asthma Bennie McWilliams, M.D. Howard Rosenblatt, M.D. Meena Ganesh, M.D. Chris Valmores, B.S.C.S.M., R.R.P.T. Carol Reagan, R.Ph. Johnny Smith Johnny is a 5
More informationOutpatient Management of Pediatric Asthma Ruth A. McConnell, MPH, MSN, RN, CPNP, AE-C
Outpatient Management of Pediatric Asthma Ruth A. McConnell, MPH, MSN, RN, CPNP, AE-C Pediatric Nurse Practitioner, Certified Asthma Educator Department of Pediatrics, Pulmonology Section Texas Children's
More informationPathology of Asthma Epidemiology
Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology
More informationADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.
ADULT ASTHMA GUIDE SUMMARY This summary provides busy health professionals with key guidance for assessing and treating adult asthma. Its source document Asthma and Respiratory Foundation NZ Adult Asthma
More informationThe methodology behind GINA and EPR-3 medication recommendations: Stepwise treatment in asthma
The methodology behind GINA and EPR-3 medication recommendations: Stepwise treatment in asthma Maureen George PhD RN AE-C FAAN Columbia University mg3656@cumc.columbia.edu Faculty Disclosures Maureen George
More information(Asthma) Diagnosis, monitoring and chronic asthma management
Dubai Standards of Care 2018 (Asthma) Diagnosis, monitoring and chronic asthma management Preface Asthma is one of the most common problem dealt with in daily practice. In Dubai, the management of chronic
More informationEnhancing Patient Care
Enhancing Patient Care I CAN control my asthma! PHYSICIAN WEB ORIENTATION COMMUNITY PEDIATRIC ASTHMA SERVICE JULY 2014 Sorry we couldn't connect in person This presentation will inform Calgary Zone physicians
More informationMedications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources
Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency
More informationASTHMA PROTOCOL CELLO
ASTHMA PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives, non medical and medical therapy and a scheme for inhaler dosage.
More informationWeb E-Mial Registration Form. Med practitioner s name. Med practitioner s phone. Name/location of the clinic
AsthmaCare Program Buteyko Clinic USA, LLC Web www.asthmacare.us E-Mial info@asthmacare.us Workshop Date Workshop location Registration Form The purpose of this form is to assist AsthmaCare practitioner
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Xolair (omalizumab) Page 1 of 15 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Xolair (omalizumab) Prime Therapeutics will review Prior Authorization requests.
More informationAsthma for Primary Care: Assessment, Control, and Long-Term Management
Asthma for Primary Care: Assessment, Control, and Long-Term Management Learning Objectives After participating in this educational activity, participants should be better able to: 1. Choose the optimal
More informationTRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationBiologic Agents in the treatment of Severe Asthma
Biologic Agents in the treatment of Severe Asthma Daniel L Maxwell, D.O., FACOI, FAASM Clinical Assistant Professor of Medicine Michigan State University College of Osteopathic Medicine College of Human
More informationAsthma. UVM. University of Vermont. Alicia Jacobs MD Fletcher Allen Health Care and the University of Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Scholarly Works 6-14-2013 Asthma Alicia Jacobs MD Fletcher Allen Health Care and the University of Vermont Follow this and additional works at:
More informationDiagnosis and Management of Asthma
Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:
More informationBreathe Easy. Living with Asthma
Breathe Easy Living with Asthma Got Asthma? You re Not Alone! More than 300 million people around the world have asthma. But having asthma doesn t have to limit what you can do. With education and treatment,
More informationGreater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma
Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma Non-pharmacological options for ALL patients, consider at ALL stages Make sure diagnosis
More informationStaying Healthy. with Asthma. Illustrations by paulsharp.com
Staying Healthy with Asthma Illustrations by paulsharp.com Lungs & Asthma What is Asthma? Inflammation or swelling of airways that leads to: 1) Mucous production deep inside the airways. 2) Temporary difficulty
More informationAsthma training. Mike Levin Division of Asthma and Allergy Red Cross Hospital
Asthma training Mike Levin Division of Asthma and Allergy Red Cross Hospital Introduction Physiology Diagnosis Severity Treatment Control Stage 3 of guidelines Acute asthma Drug delivery Conclusion Overview
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationAsthma Education. The Keys to Asthma Prevention and Control. what to do when one s asthma is flared! Lucile Packard Children s Hospital.
Asthma Education Lucile Packa r d Children s H o spit al Created by Rachel Lawler RN, MSN, cpnp, AE-C, NPAT Pulmonary Pediatric Nurse Practitioner Lucile Packard Children s Hospital The Keys to Asthma
More information